Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Queensland Health
Mallinckrodt
Chinese Patent Office
Moodys

Generated: August 17, 2019

DrugPatentWatch Database Preview

Litigation Details for Genentech, Inc. v. Pfizer, Inc. (D. Del. 2017)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Genentech, Inc. v. Pfizer, Inc. (D. Del. 2017)

Docket   Try a Free Trial Date Filed 2017-11-17
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties CITY OF HOPE; GENENTECH, INC.; PFIZER, INC.
Patents 7,449,184; 7,485,704; 7,807,799; 8,512,983; 8,691,232; 9,714,293
Attorneys Aaron M. Nelson; Adam R. Brausa; Alexandra M. Ewing; Andrew J. Danford; Dan Constantinescu; Daralyn J. Durie; Diana G. Santos; Dominick T. Gattuso; Emily R. Whelan; Frederick L. Cottrell , III; Jason James Rawnsley; Kevin S. Prussia; Lisa J. Pirozzolo; Michael W. Johnson; Nancy L. Schroeder; Nora Q.E. Passamaneck; Robert J. Gunther , Jr.; Robert M. Galvin; Stephanie Neely; Thomas J. Meloro; Timothy Cook; William F. Lee
Firms Heyman Enerio Gattuso & Hirzel LLP
Link to Docket External link to docket
Biologic Drugs cited in Genentech, Inc. v. Pfizer, Inc.

The biologic drugs covered by the patents cited in this case are   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial , and   Try a Free Trial .

Details for Genentech, Inc. v. Pfizer, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-01-10 11 infringe U.S. Patent No. 7,449,184. 303. The claims of U.S. Patent No. 7,449,184 are invalid… the Patent Office. Pfizer admits that what purports to be a copy of U.S. Patent No. 7,449,184 was attached…right to enforce the ’660 patent. 55. U.S. Patent No. 7,449,184 is titled “Fixed Dosing of…obviousness-type double patenting. 304. U.S. Patent No. 7,449,184 describes and claims an … 50. Pfizer admits that U.S. Patent Nos. 7,501,122, 7,449,184, and 8,691,232 respectively purport External link to document
2017-11-17 3 ; 8,822,655; 9,428,766; 9,487,809; 9,714,293; 7,449,184; 7,501,122; 7,993,834; 8,076,066; 8,425,908; 8,440,402… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,331,415; 7,923,221…17 November 2017 1:17-cv-01672 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Mallinckrodt
Deloitte
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.